Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163602968> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2163602968 endingPage "A420" @default.
- W2163602968 startingPage "A420" @default.
- W2163602968 abstract "Cervical cancer (CC) remains the leading cause of cancer death among Colombian women. Human papillomavirus (HPV) 16 and 18 infection is associated with CC while HPV 6 and 11 are related to genital warts (GW). Currently are available 2 vaccines against HPV. Bivalent protects against carcinogenic genotypes and tetravalent also protects against genotypes GW associated. We present the cost-effectiveness evaluation of the introduction of two vaccination strategies in Colombian women taking into account the current screening program. We designed a Markov model, which simulates the natural history of CC and GW in a cohort of women. The occurrence parameters were extracted and validated with a literature review and national databases. The costs were estimated from costing of standard cases. We estimated the impact of the introduction of bivalent and tetravalent HPV vaccines. We compared the different strategies in a competitive scenario and built the ICERs. A sensitivity analysis was carried out. In a cohort of 430,859 women followed for the entire life without vaccination or screening programs 15,284 CC cases and 18,275 GW episodes may occur. The CC would cause 4733 deaths. The screening program would prevent 3015 CC deaths. Either vaccination alternatives prevents 1958 CC deaths additional to screening program, and they are cost-effective when compared against non-vaccination. In a competitive analysis, vaccination with bivalent+screnning is dominated while vaccination with tetravalent+screening is cost-effective (ICER per DALY averted US $ 1239). The results are sensitive to changes in the parameters of progression of neoplastic disease. Economic evaluation of HPV vaccines in Colombian scenario shows that bivalent vaccination is a dominated strategy, while tetravalent vaccination is cost-effective at a willingness to pay less than 1 GDP per capita per DALY averted. The relative advantage of tetravalent is due to avoided of costs and DALYs due to GW." @default.
- W2163602968 created "2016-06-24" @default.
- W2163602968 creator A5025124890 @default.
- W2163602968 creator A5047049159 @default.
- W2163602968 creator A5049798741 @default.
- W2163602968 creator A5084532124 @default.
- W2163602968 date "2012-11-01" @default.
- W2163602968 modified "2023-09-27" @default.
- W2163602968 title "PCN65 Cost-Effectiveness Analysis of Introducing HPV Vaccines in Colombian Women" @default.
- W2163602968 doi "https://doi.org/10.1016/j.jval.2012.08.2105" @default.
- W2163602968 hasPublicationYear "2012" @default.
- W2163602968 type Work @default.
- W2163602968 sameAs 2163602968 @default.
- W2163602968 citedByCount "0" @default.
- W2163602968 crossrefType "journal-article" @default.
- W2163602968 hasAuthorship W2163602968A5025124890 @default.
- W2163602968 hasAuthorship W2163602968A5047049159 @default.
- W2163602968 hasAuthorship W2163602968A5049798741 @default.
- W2163602968 hasAuthorship W2163602968A5084532124 @default.
- W2163602968 hasBestOaLocation W21636029681 @default.
- W2163602968 hasConcept C112930515 @default.
- W2163602968 hasConcept C121608353 @default.
- W2163602968 hasConcept C126322002 @default.
- W2163602968 hasConcept C143998085 @default.
- W2163602968 hasConcept C144024400 @default.
- W2163602968 hasConcept C149923435 @default.
- W2163602968 hasConcept C203014093 @default.
- W2163602968 hasConcept C22070199 @default.
- W2163602968 hasConcept C2778220009 @default.
- W2163602968 hasConcept C2778308922 @default.
- W2163602968 hasConcept C2778580637 @default.
- W2163602968 hasConcept C2780009117 @default.
- W2163602968 hasConcept C29456083 @default.
- W2163602968 hasConcept C3019080777 @default.
- W2163602968 hasConcept C515549039 @default.
- W2163602968 hasConcept C71924100 @default.
- W2163602968 hasConcept C72563966 @default.
- W2163602968 hasConceptScore W2163602968C112930515 @default.
- W2163602968 hasConceptScore W2163602968C121608353 @default.
- W2163602968 hasConceptScore W2163602968C126322002 @default.
- W2163602968 hasConceptScore W2163602968C143998085 @default.
- W2163602968 hasConceptScore W2163602968C144024400 @default.
- W2163602968 hasConceptScore W2163602968C149923435 @default.
- W2163602968 hasConceptScore W2163602968C203014093 @default.
- W2163602968 hasConceptScore W2163602968C22070199 @default.
- W2163602968 hasConceptScore W2163602968C2778220009 @default.
- W2163602968 hasConceptScore W2163602968C2778308922 @default.
- W2163602968 hasConceptScore W2163602968C2778580637 @default.
- W2163602968 hasConceptScore W2163602968C2780009117 @default.
- W2163602968 hasConceptScore W2163602968C29456083 @default.
- W2163602968 hasConceptScore W2163602968C3019080777 @default.
- W2163602968 hasConceptScore W2163602968C515549039 @default.
- W2163602968 hasConceptScore W2163602968C71924100 @default.
- W2163602968 hasConceptScore W2163602968C72563966 @default.
- W2163602968 hasIssue "7" @default.
- W2163602968 hasLocation W21636029681 @default.
- W2163602968 hasOpenAccess W2163602968 @default.
- W2163602968 hasPrimaryLocation W21636029681 @default.
- W2163602968 hasRelatedWork W2000321080 @default.
- W2163602968 hasRelatedWork W2008682709 @default.
- W2163602968 hasRelatedWork W2010666657 @default.
- W2163602968 hasRelatedWork W2049955140 @default.
- W2163602968 hasRelatedWork W2138135112 @default.
- W2163602968 hasRelatedWork W2168007028 @default.
- W2163602968 hasRelatedWork W2404982942 @default.
- W2163602968 hasRelatedWork W2912353493 @default.
- W2163602968 hasRelatedWork W4220709447 @default.
- W2163602968 hasRelatedWork W55895756 @default.
- W2163602968 hasVolume "15" @default.
- W2163602968 isParatext "false" @default.
- W2163602968 isRetracted "false" @default.
- W2163602968 magId "2163602968" @default.
- W2163602968 workType "article" @default.